Establishes "Kidney Disease Prevention and Education Task Force."
Assembly Bill 1014 establishes the “Kidney Disease Prevention and Education Task Force” within the Department of Health. The task force is directed to develop and implement a public awareness campaign on early detection and treatment of kidney disease, including health education, preventive screenings, and outreach through social media, television, and radio. It is also charged with examining racial disparities in chronic kidney disease, kidney transplantation, and living and deceased kidney donation, and with recommending a statewide, cost-effective plan for early screening, diagnosis, and treatment.
The bill creates an 11-member task force made up of legislators, health officials, and public members with relevant expertise or lived experience, including a nephrologist, a primary care physician, a pharmaceutical representative, a dialysis center representative, and a person living with chronic kidney disease. The Department of Health must provide staff support, meetings must be open to the public, and materials must be posted online. The task force must report its findings and recommendations to the Governor and Legislature within two years of organizing, and it expires 30 days after issuing its report.
If enacted, the bill would add a temporary advisory body to the Department of Health but would not directly change existing kidney disease treatment laws or insurance rules. Its practical effect would be to generate policy recommendations, public education strategies, and possible future legislative or administrative proposals related to screening, diagnosis, treatment access, and health equity in kidney care. It would also formally incorporate racial disparity analysis into state-level kidney disease policy planning.
The bill’s tone is strongly supportive of public health intervention and prevention, with the findings emphasizing the seriousness of chronic kidney disease, the value of early detection, and the need to address inequities affecting Black and Hispanic residents. Because there are no committee transcripts or recorded votes provided, there is no evidence of opposition in the available materials. The bill appears framed as a consensus-oriented health policy measure focused on education, screening, and equity.
No specific contention is documented in the available record, but the bill’s emphasis on racial disparities and health equity could draw attention to unequal outcomes in kidney disease, transplantation, and donation. Potential areas of policy debate may include the cost and design of a statewide screening campaign, the role of public outreach versus direct clinical intervention, and the inclusion of industry and dialysis-center representatives on the task force. The requirement to study disparities and recommend statewide action suggests the bill is more exploratory than regulatory, which may reduce immediate controversy.